Discovering novel antibodies derived from the human body itself to treat neurodegenerative diseases

Project description

An eagle's eye for antibodies associated with rare diseases may revolutionise therapy

Fields of science

• medical and health sciences › basic medicine › immunology

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

MABYLON AG

Address

Wagistrasse 14
8952 Schlieren
Switzerland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 50 000